Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VRDN · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
2.00
Buy/Sell (by trades)
Overall sentiment
Viridian Therapeutics, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
VRDN insider buying and selling by quarter
VRDN insider selling · VRDN insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · VRDN ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VRDN executive sell shares · VRDN board member insider trading · VRDN insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 11, 2026 | Fairmount Funds Management LLC Director | Purchase | 1,176,470 | $20.00M⚡ | Form 4 |
| Mar 3, 2026 | Tousignant Jennifer Chief Legal Officer | Option | 5,169 | — | Form 4 |
| Mar 3, 2026 | Tousignant Jennifer Chief Legal Officer | Other | 1,724 | $51K | Form 4 |
| Mar 3, 2026 | Harmon Seth CFO | Option | 6,267 | — | Form 4 |
| Mar 3, 2026 | Harmon Seth CFO | Other | 2,091 | $61K | Form 4 |
| Mar 3, 2026 | Beetham Thomas W. COO | Option | 9,409 | — | Form 4 |
| Mar 3, 2026 | Beetham Thomas W. COO | Other | 3,138 | $92K | Form 4 |
| Mar 3, 2026 | Mahoney Stephen F. President and CEO | Option | 18,357 | — | Form 4 |
| Mar 3, 2026 | Mahoney Stephen F. President and CEO | Other | 7,627 | $224K | Form 4 |
| Dec 31, 2025 | Tousignant Jennifer Chief Legal Officer | Sale | 2,272 | $71K | Form 4 |
| Oct 23, 2025 | Fairmount Funds Management LLC Director | Purchase | 454,545 | $10.00M⚡ | Form 4 |
| Jun 10, 2025 | Fairmount Funds Management LLC Director | Option | 12,500 | $154K | Form 4 |
| Jun 9, 2025 | Fairmount Funds Management LLC Director | Option | 1,600 | $12K | Form 4 |
| Sep 27, 2024 | Beetham Thomas W. COO | Purchase | 5,000 | $117K | Form 4 |
| Sep 27, 2024 | Mahoney Stephen F. President and CEO · Director | Purchase | 21,400 | $499K | Form 4 |
| Sep 13, 2024 | Fairmount Funds Management LLC Director | Purchase | 1,600,000 | $30.00M⚡ | Form 4 |
| Mar 28, 2024 | Fairmount Funds Management LLC Director | Other | 5,859 | — | Form 4 |
| Mar 28, 2024 | Fairmount Funds Management LLC Director | Other | 5,859 | — | Form 4 |
| Jan 22, 2024 | Fairmount Funds Management LLC Director | Purchase | 476,190 | $10.00M⚡ | Form 4 |
| Jun 15, 2023 | Meisner Lara Chief Legal Officer | Option | 2,269 | $52K | Form 4 |
| Jun 16, 2023 | Meisner Lara Chief Legal Officer | Option | 27 | $622 | Form 4 |
| Jun 15, 2023 | Meisner Lara Chief Legal Officer | Sale | 2,269 | $64K | Form 4 |
| Jun 16, 2023 | Meisner Lara Chief Legal Officer | Sale | 27 | $765 | Form 4 |
| Jun 6, 2023 | Meisner Lara Chief Legal Officer | Option | 5,126 | $95K | Form 4 |
| Jun 2, 2023 | Meisner Lara Chief Legal Officer | Option | 1,875 | $26K | Form 4 |
Fairmount Funds Management LLC
Director
Date
May 11
Shares
1,176,470
Price
$17.00
Value
$20.00M ⚡
Tousignant Jennifer
Chief Legal Officer
Date
Mar 3
Shares
1,724
Price
$29.32
Value
$51K
Mahoney Stephen F.
President and CEO
Date
Mar 3
Shares
7,627
Price
$29.32
Value
$224K
Tousignant Jennifer
Chief Legal Officer
Date
Dec 31
Shares
2,272
Price
$31.16
Value
$71K
Fairmount Funds Management LLC
Director
Date
Oct 23
Shares
454,545
Price
$22.00
Value
$10.00M ⚡
Fairmount Funds Management LLC
Director
Date
Jun 10
Shares
12,500
Price
$12.31
Value
$154K
Fairmount Funds Management LLC
Director
Date
Jun 9
Shares
1,600
Price
$7.80
Value
$12K
Mahoney Stephen F.
President and CEO · Director
Date
Sep 27
Shares
21,400
Price
$23.33
Value
$499K
Fairmount Funds Management LLC
Director
Date
Sep 13
Shares
1,600,000
Price
$18.75
Value
$30.00M ⚡
Fairmount Funds Management LLC
Director
Date
Jan 22
Shares
476,190
Price
$21.00
Value
$10.00M ⚡
Meisner Lara
Chief Legal Officer
Date
Jun 15
Shares
2,269
Price
$23.03
Value
$52K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VRDN insider trading
VRDN insider trades
Viridian Therapeutics, Inc. (VRDN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Fairmount Funds Management LLC (Director), Tousignant Jennifer (Chief Legal Officer), Harmon Seth (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. VRDN insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Viridian Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VRDN insider trading · 5 questionsThe insiders of Viridian Therapeutics, Inc. (VRDN) include executives and directors such as Fairmount Funds Management LLC (Director), Tousignant Jennifer (Chief Legal Officer), Harmon Seth (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026